Entheon Biomedical Corp.
Entheon Biomedical Corp.
CSE Index:
NoCurrency:
CAD Entheon is a biotechnology research and development company interested in treating addiction and substance use disorders.
Entheon Biomedical Corp. (ENBI)
0.14
0.03 (27.27%)
Entheon Biomedical Corp. (ENBI)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Bid Size
2,000
Bid Price
0.12
Ask Price
0.14
Ask Size
3,500
Volume
2,200
Last Price
0.14
Tick
Net Change
0.03
Prev Close
0.11
Open
0.14
Day High
0.14
Day Low
0.14
52 Week High
0.45
52 Week Low
0.075
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
50,000
Bid Price
0.005
Ask Price
0.00
Ask Size
0
Volume
0
Last Price
0.15
Tick
Net Change
Prev Close
0.15
Open
0.00
Day High
0.00
Day Low
0.00
52 Week High
52 Week Low
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
2,000
Bid Price
0.12
Ask Price
0.14
Ask Size
3,500
Volume
2,200
Last Price
0.14
Tick
Net Change
0.03
Prev Close
0.11
Open
0.14
Day High
0.14
Day Low
0.14
52 Week High
0.45
52 Week Low
0.075
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
50,000
Bid Price
0.005
Ask Price
0.00
Ask Size
0
Volume
0
Last Price
0.15
Tick
Net Change
Prev Close
0.15
Open
0.00
Day High
0.00
Day Low
0.00
52 Week High
52 Week Low
*Note: Bid Size and Ask Size fields are displayed as actual quantities
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| National Bank Financial Inc. | 1,000 | 0.12 | 0.14 | 2,500 | National Bank Financial Inc. |
| TD Securities Inc. | 1,000 | 0.12 | 0.14 | 1,000 | CIBC World Markets Inc. |
| RBC Capital Markets | 95,000 | 0.115 | 0.15 | 30,000 | RBC Capital Markets |
| TD Securities Inc. | 30,000 | 0.11 | 0.17 | 4,000 | Anonymous |
| RBC Capital Markets | 21,000 | 0.11 | 0.175 | 20,000 | TD Securities Inc. |
| RBC Capital Markets | 44,500 | 0.105 | 0.18 | 1,000 | Anonymous |
| Anonymous | 34,000 | 0.10 | 0.19 | 12,000 | National Bank Financial Inc. |
| Anonymous | 25,000 | 0.085 | 0.30 | 4,500 | National Bank Financial Inc. |
| TD Securities Inc. | 9,000 | 0.075 | 0.31 | 5,000 | Anonymous |
| TD Securities Inc. | 37,000 | 0.055 | 0.315 | 2,000 | Anonymous |
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| Anonymous | 50,000 | 0.005 | 0.00 | 0 | |
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 2 | 2,000 | 0.12 | 0.14 | 3,500 | 2 |
| 1 | 95,000 | 0.115 | 0.15 | 30,000 | 1 |
| 2 | 51,000 | 0.11 | 0.17 | 4,000 | 1 |
| 1 | 44,500 | 0.105 | 0.175 | 20,000 | 1 |
| 1 | 34,000 | 0.10 | 0.18 | 1,000 | 1 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 1 | 50,000 | 0.005 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| Date/Time | Price | Change | Volume | Buyer | Seller | Venue |
|---|---|---|---|---|---|---|
| Apr 17, 19:37 | 0.14 | 0.03 | 500 | Interactive Brokers Canada Inc. | National Bank Financial Inc. | CSE |
| Apr 17, 19:37 | 0.14 | 0.03 | 1,500 | TD Securities Inc. | National Bank Financial Inc. | CSE |
| Apr 16, 13:35 | 0.11 | 0.00 | 23,000 | RBC Capital Markets | Fidelity Clearing Canada ULC | CSE |
| Apr 16, 13:31 | 0.115 | 0.005 | 500 | CIBC World Markets Inc. | Fidelity Clearing Canada ULC | CSE |
| Apr 16, 13:31 | 0.11 | 0.00 | 30,000 | Leede Jones Gable | Fidelity Clearing Canada ULC | CSE |
Company Info
Address
Suite 720-999 W Broadway Street
Vancouver, BC V5Z 1K5
CanadaPhone
604-562-3932Email
info@entheonbiomedical.comWebsite
https://entheonbiomedical.com/Listing date
Thursday, May 3, 2018Transfer Agent
Olympia Trust CompanyAuditor
Manning Elliott LLPSEDAR Information
Filing Type
Any
News Releases
Management's Discussion & Analysis
Financial Statements
Material Change Report
Timeframe
1 week1 month3 month6 month1 yearAll Time
Entheon Biomedical Corp.
Date:
Jan 9, 2025
Entheon Biomedical Corp.
Date:
Aug 6, 2024
Entheon Biomedical Corp.
Date:
May 1, 2024
Entheon Biomedical Corp.
Date:
Apr 22, 2024
Entheon Biomedical Corp.
Date:
Mar 25, 2024
Entheon Biomedical Corp.
Date:
Mar 25, 2024
Entheon Biomedical Corp.
Date:
Apr 19, 2023
Entheon Biomedical Corp.
Date:
Mar 23, 2023
Entheon Biomedical Corp.
Date:
Mar 23, 2023
Entheon Biomedical Corp.
Date:
Mar 20, 2023
Entheon Biomedical Corp.
Date:
May 30, 2022
Entheon Biomedical Corp.
Date:
Apr 27, 2022
Entheon Biomedical Corp.
Date:
Apr 27, 2022
Entheon Biomedical Corp.
Date:
Mar 30, 2022
Entheon Biomedical Corp.
Date:
Mar 15, 2022
Entheon Biomedical Corp.
Date:
Oct 18, 2021
Entheon Biomedical Corp.
Date:
May 31, 2021
Entheon Biomedical Corp.
Date:
Mar 30, 2021
Entheon Biomedical Corp.
Date:
Dec 31, 2020
Entheon Biomedical Corp.
Date:
Oct 13, 2020
Entheon Biomedical Corp.
Date:
Oct 13, 2020
Entheon Biomedical Corp.
Date:
Oct 13, 2020
Entheon Biomedical Corp.
Date:
Oct 13, 2020
Entheon Biomedical Corp.
Date:
Jun 15, 2020
Entheon Biomedical Corp.
Date:
Jun 15, 2020
Entheon Biomedical Corp.
Date:
Jun 15, 2020
Entheon Biomedical Corp.
Date:
Jun 15, 2020
Entheon Biomedical Corp.
Date:
Jun 12, 2020
Entheon Biomedical Corp.
Date:
Jun 3, 2019
Entheon Biomedical Corp.
Date:
Feb 18, 2019
Entheon Biomedical Corp.
Date:
Nov 19, 2018
Entheon Biomedical Corp.
Date:
Nov 19, 2018
Entheon Biomedical Corp.
Date:
Nov 19, 2018
Entheon Biomedical Corp.
Date:
Nov 19, 2018
Entheon Biomedical Corp.
Date:
Apr 6, 2018
Entheon Biomedical Corp.
Date:
Jan 16, 2018
Entheon Biomedical Corp.
Date:
Dec 8, 2017
Company Info
Address
Suite 720-999 W Broadway Street
Vancouver, BC V5Z 1K5
CanadaPhone
604-562-3932Email
info@entheonbiomedical.comWebsite
https://entheonbiomedical.com/Listing date
Thursday, May 3, 2018Transfer Agent
Olympia Trust CompanyAuditor
Manning Elliott LLPCapitalization
Issued & Outstanding:
13858934Reserved for Issuance:
8090000Company Officers
Timothy Ko, CEO
Soo-Whan Kim, Interim CFO
News Releases
07/04/2025
Entheon Announces Change of Directors
04/04/2025
Entheon Announces Change of Directors
Bulletins
28/02/2024
2024-0235 – Consolidation - Entheon Biomedical Corp. (ENBI)
Le 28 février/February 2024
Entheon Biomedical Corp. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every ten (10) pre-consolidated common shares.
As a result, the outstanding shares of the company will be reduced to approximately 5,908,926 common shares.
The name and symbol will not change.
